Zinc as a modulator of transglutaminase activity - Laboratory and pathophysiological aspects.

J Transl Autoimmun

Lund University, Skåne University Hospital Malmö, Department of Internal Medicine, Malmö, Sweden.

Published: June 2021

For a whole century, citrate has been used as an anticoagulant via chelation of calcium. Later, also EDTA was introduced as an anticoagulant. An often overlooked fact is that zinc is bound to citrate and EDTA with affinities much greater than that for calcium, imposing problems in biomedical research. , proteins of the S100 family are released from leukocytes and known to bind calcium. Some of them, e.g., calprotectin, also chelate zinc. Thus, at an inflamed site, the ratio between Ca and Zn is changed. This mechanism is of importance for the modulation of the activation of a fascinating family of post-translationally acting calcium-dependent thiol enzymes, the transglutaminases, which are inhibited by zinc. This presentation illustrates the complexity of studies with zinc. Moreover, it exemplifies the role of Zn in pathophysiological situations such as celiac disease and neurodegeneration.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233124PMC
http://dx.doi.org/10.1016/j.jtauto.2021.100110DOI Listing

Publication Analysis

Top Keywords

zinc
5
zinc modulator
4
modulator transglutaminase
4
transglutaminase activity
4
activity laboratory
4
laboratory pathophysiological
4
pathophysiological aspects
4
aspects century
4
century citrate
4
citrate anticoagulant
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!